Home >> Chemicals & Materials >> Enoxaparin Sodium Market

Global Enoxaparin Sodium Market Size,Trends, Growth Forecast to 2031

Category : Chemicals & Materials | Report Code : 277 | Pages : 141 | Oct 2024

Report Overview

Enoxaparin sodium is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis.

The global Enoxaparin Sodium market size is projected to grow from US$ 3504 million in 2024 to US$ 5377 million in 2030; it is expected to grow at a CAGR of 7.4% from 2024 to 2030.

Analytic Insights Hub (AIH) ' newest research report, the “Enoxaparin Sodium Industry Forecast” looks at past sales and reviews total world Enoxaparin Sodium sales in 2023, providing a comprehensive analysis by region and market sector of projected Enoxaparin Sodium sales for 2024 through 2030. With Enoxaparin Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enoxaparin Sodium industry.

This Insight Report provides a comprehensive analysis of the global Enoxaparin Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enoxaparin Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Enoxaparin Sodium market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enoxaparin Sodium and breaks down the forecast by Type, by Sales Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enoxaparin Sodium.

The core global manufacturers of enoxaparin sodium include Sanofi, Teva, Techdow (Hepalink),  Fresenius Kabi, Rovi and Amphastar. The top three manufacturers account for approximately 66% of the global share. Sanofi is the world's largest manufacturer of enoxaparin sodium, with a market share of approximately 42%.

Europe is the world's largest enoxaparin sodium market, accounting for nearly 60% of the market share. The second and third places are North America and Asia, accounting for 19% and 16% respectively.

In terms of product type, 60 mg/0.6mL occupies a dominant position, accounting for 29% of the market share. At the same time, in terms of sales channels, hospitals and clinics are the main sales channels, accounting for 80%.

This report presents a comprehensive overview, market shares, and growth opportunities of Enoxaparin Sodium market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    20 mg/0.2mL
    30 mg/0.3mL
    40 mg/0.4mL
    60 mg/0.6mL
    80 mg/0.8mL
    100 mg/1mL
    120 mg/0.8mL
    150 mg/1mL
    300mg/3mL

Segmentation by Sales Channel:
    Hospital & Clinic
    Pharmacy
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Sanofi
    Techdow (Hepalink)
    Teva
    Nanjing King-friend
    Rovi
    Fresenius Kabi
    Fosun Pharma(Gland Pharma)
    Amphastar
    Sandoz (Novartis)
    Apotex
    Huadong Medicine
    Cipla
    Taj Pharma
    Chengdu Baiyu Pharmaceutical
    Changzhou Qianhong Bio-pharma
    Beijing SL Pharmaceutical

Key Questions Addressed in this Report
What is the 10-year outlook for the global Enoxaparin Sodium market?
What factors are driving Enoxaparin Sodium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enoxaparin Sodium market opportunities vary by end market size?
How does Enoxaparin Sodium break out by Type, by Sales Channel?

Frequently Asked Questions?

Ans - The purpose of a Enoxaparin Sodium market research report is to provide data-driven insights and analysis on a Enoxaparin Sodium market. It helps businesses understand industry trends, competition, consumer behavior, market size, growth potential, and risks, supporting strategic decision-making.

Ans - Market research reports typically include both quantitative (market size, revenue, growth rates) and qualitative (trends, consumer preferences, competitive analysis) data. It often includes industry statistics, surveys, expert opinions, historical data, and future forecasts.

Ans - The forecast period typically for Enoxaparin Sodium market report spans the next 5 to 10 years. It includes projected market trends, growth opportunities, and potential challenges.

Ans - Yes, Analytic Insights Hub customization services, allowing businesses to focus on specific geographies, sectors, or market segments that are relevant to them.

Ans - The report highlights major trends such as technological innovations, consumer behavior shifts, regulatory changes, or emerging markets that may impact the industry?s growth.